Browse All

Current Filters

CLEAR FILTER x

TITLE

Category-Classification:

e012 Biologic Disease-Modifying Antirheumatic Drugs Do Not Increase Risk for Periprosthetic Joint Infection

e013 Incidence of Undiagnosed Diabetes during Total Joint Arthroplasty

e014 Utility of Frailty Index and Risk Assessment Prediction Tool in Predicting Discharge Disposition and Prolonged Length of Stay following Enhanced Recovery after Surgery Total Hip and Knee Arthroplasty

e015 Perioperative Cefazolin for Surgical Prophylaxis in Total Joint Replacement Patients with a Self-Reported Penicillin Allergy: Is It Safe?

e016 Improved Accuracy of the Risk Assessment and Prediction Tool in Extended Length of Stay Patients following Total Hip Arthroplasty